Clinical Medicine Research Center, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, China.
Institute of Cancer, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, China.
Sci Adv. 2019 Nov 13;5(11):eaax0629. doi: 10.1126/sciadv.aax0629. eCollection 2019 Nov.
The mechanisms that drive programmed resolution of inflammation remain elusive. Here, we report the temporal regulation of soluble (s) and transmembrane (m) fibrinogen-like protein 2 (Fgl2) during inflammation and show that both sFgl2 and mFgl2 correlate with the outcome. The expression and ectodomain shedding of Fgl2 are respectively promoted by miR-466l and metalloproteinases (ADAM10 and ADAM17) during inflammation resolution. Deficiency of Fgl2 enhances polymorphonuclear neutrophil (PMN) infiltration but impairs macrophage (MΦ) maturation and phagocytosis and inhibits the production of n-3 docosapentaenoic acid-derived resolvin 5 (RvDp5). In contrast, administration of sFgl2 blunts PMN infiltration as well as promotes PMN apoptosis and RvDp5 biosynthesis. By activating ALX/FPR2, RvDp5 enhances sFgl2 secretion via ADAM17 and synergistically accelerates resolution of inflammation. These results uncover a previously unknown endogenous programmed mechanism by which Fgl2 regulates resolution of inflammation and shed new light on clinical sepsis treatments.
驱动炎症程序性消退的机制仍然难以捉摸。在这里,我们报告了可溶性(s)和跨膜(m)纤维蛋白原样蛋白 2(Fgl2)在炎症过程中的时间调节,并表明 sFgl2 和 mFgl2 均与结果相关。在炎症消退过程中,miR-466l 和金属蛋白酶(ADAM10 和 ADAM17)分别促进 Fgl2 的表达和胞外结构域脱落。Fgl2 缺陷增强多形核粒细胞(PMN)浸润,但损害巨噬细胞(MΦ)成熟和吞噬作用,并抑制 n-3 二十二碳五烯酸衍生的分辨率 5(RvDp5)的产生。相比之下,sFgl2 的给药会削弱 PMN 的浸润,并促进 PMN 的凋亡和 RvDp5 的生物合成。通过激活 ALX/FPR2,RvDp5 通过 ADAM17 激活 sFgl2 分泌,并协同加速炎症消退。这些结果揭示了一种以前未知的内源性程序性机制,Fgl2 通过该机制调节炎症消退,并为临床败血症治疗提供了新的思路。